Hyperconcentrated glabellar injections to mitigate risk of botulinum toxin A-induced blepharoptosis: An unnecessary precaution
Journal of the American Academy of Dermatology · 2024
DOI: 10.1016/j.jaad.2023.12.026 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of the American Academy of Dermatology, 2024. Verfasst von Jessica G Labadie und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, The Icahn School of Medicine at Mount Sinai, New York, New York. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Blepharoptosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, The Icahn School of Medicine at Mount Sinai, New York, New York.
- SkinCare Physicians, Chestnut Hill, Massachusetts; Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut; Department of Dermatology, The Warren Alpert Medical School of Brown University,…
Zitieren
APA
Labadie, J. G., & Dover, J. S. (2024). Hyperconcentrated glabellar injections to mitigate risk of botulinum toxin A-induced blepharoptosis: An unnecessary precaution. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2023.12.026
Vancouver
Labadie JG, Dover JS. Hyperconcentrated glabellar injections to mitigate risk of botulinum toxin A-induced blepharoptosis: An unnecessary precaution. Journal of the American Academy of Dermatology. 2024. doi:10.1016/j.jaad.2023.12.026
BibTeX
@article{Labadie2024,
author = {Labadie, Jessica G and Dover, Jeffrey S},
title = {Hyperconcentrated glabellar injections to mitigate risk of botulinum toxin A-induced blepharoptosis: An unnecessary precaution},
journal = {Journal of the American Academy of Dermatology},
year = {2024},
doi = {10.1016/j.jaad.2023.12.026}
}
EUVIMED